Fulcrum Therapeutics

FULC · NASDAQ

$3.72+$0.02 (+0.54%)TodayMarket closed ·
Prev close $3.70

Latest news

  • Press releasePRNewswire

    Are BWIN, PTC, FULC, PRTH Obtaining Fair Deals for their Shareholders?

  • Press releaseNewsfile

    Kaplan Fox is Investigating Claims Against Fulcrum Therapeutics, Inc. (FULC) on Behalf of Investors

  • Press releaseNewsfile

    Kaplan Fox Encourages Fulcrum Therapeutics, Inc. (FULC) Investors Who Suffered Losses to Learn About Their Legal Rights

  • Press releaseNewsfile

    Kaplan Fox Investor Alert: Fulcrum Therapeutics, Inc. (FULC) Investigated for Possible Securities Law Violations

  • Press releaseNewsfile

    Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (FULC) and its Board for Possible Securities Law Violations

  • Press releaseNewsfile

    Kaplan Fox Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of a Pending Securities Investigation

  • Press releasePRNewswire

    Are FULC, TCBK, LXP Obtaining Fair Deals for their Shareholders?

  • Press releaseNewsfile

    Kaplan Fox Alerts Fulcrum Therapeutics, Inc. (FULC) Investors: The Firm is Investigating Possible Securities Law Violations

  • Press releaseNewsfile

    Kaplan Fox Broadens its Investigation of Fulcrum Therapeutics, Inc. (FULC) for Possible Securities Law Violations

  • Press releasePRNewswire

    Are FULC, WEAV, BWIN Obtaining Fair Deals for their Shareholders?

  • Press releaseNewsfile

    Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (FULC) to Learn More About the Firm's Investigation

  • Press releaseNewsfile

    Kaplan Fox Shareholder Alert: Fulcrum Therapeutics, Inc. (FULC) is Under Investigation for Possible Securities Law Violations

  • Press releasePRNewswire

    Are ARX, FULC, EFSI Obtaining Fair Deals for their Shareholders?

  • Press releaseNewsfile

    Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (FULC) for Investors Who Suffered Losses

  • Press releaseNewsfile

    Kaplan Fox Urges Investors of Fulcrum Therapeutics, Inc. (FULC) with Losses to Contact the Firm

  • Press releasePRNewswire

    Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders?

  • Press releaseNewsfile

    Kaplan Fox Reminds Investors of Fulcrum Therapeutics, Inc. (FULC) of an Ongoing Securities Investigation

  • Press releaseBusiness Wire

    FULC Stock Alert: Halper Sadeh LLC is Investigating Whether Fulcrum Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

  • Press releaseNewsfile

    Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (FULC) on Behalf of Shareholders for Possible Securities Law Violations

  • Press releaseNewsfile

    Kaplan Fox Advises Investors of Fulcrum Therapeutics, Inc. (FULC) to Contact the Firm Regarding a Securities Investigation

  • Press releasePRNewswire

    Are UTZ, ITGR, FULC Obtaining Fair Deals for their Shareholders?

  • Press releaseNewsfile

    Kaplan Fox Notifies Investors of Fulcrum Therapeutics, Inc. (FULC) of a Securities Law Investigation

  • Press releasePRNewswire

    Are UTZ, VCTR, FULC, CZR Obtaining Fair Deals for their Shareholders?

  • Press releaseNewsfile

    Kaplan Fox Encourages Fulcrum Therapeutics, Inc. (FULC) Investors to Contact the Firm Regarding a Securities Investigation

  • Press releaseNewsfile

    Kaplan Fox Alerts Investors of Fulcrum Therapeutics, Inc. (FULC) to a Securities Law Investigation

  • NewsVandana Singh

    Fulcrum Therapeutics Strikes All-Stock Merger With Slate Medicines

  • Press releaseGlobe Newswire

    Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies

  • Press releasePRNewswire

    Fulcrum Therapeutics, Inc. (FULC) Securities Fraud Investigation - Levi & Korsinsky

  • Press releaseGlobe Newswire

    Levi & Korsinsky Announces Investigation of Securities Claims Against Fulcrum Therapeutics, Inc. (FULC)

  • Press releaseBusiness Wire

    FULC Investor Alert: Levi & Korsinsky Investigates Fulcrum Therapeutics, Inc. (FULC) for Potential Securities Fraud

  • NewsVandana Singh

    What's Going On With Fulcrum Therapeutics Stock On Thursday?

  • Press releasePRNewswire

    Fulcrum Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Fulcrum Therapeutics, Inc. (FULC)

  • NewsAvi Kapoor

    Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

  • NewsTanya Rawat

    FULC Stock Crashes After Hours: What Investors Need To Know

  • News

    Fulcrum Therapeutics Q1 2026 Earnings Call: Complete Transcript

  • News

    Earnings Scheduled For April 27, 2026

  • NewsAvi Kapoor

    Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • NewsAvi Kapoor

    This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

  • NewsAvi Kapoor

    Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

  • NewsAvi Kapoor

    Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.